Related Experiment Videos
[The cytotoxicity of strophanthin G and digoxin]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|May 1, 1992
Abstract:
Cytotoxicity of strophanthin G and digoxin was studied in experiments on lymphoid cells and carcinoma of cervix uteri cells. The glycosides inhibited the growth of three strains of cultured tumor cells tested. It has been found that highly toxic doses of the drugs produced no changes in the cell multiplication of normal human fibroblasts.
Insights
Strophanthin G and digoxin exhibit cytotoxicity against cultured tumor cells, including cervical carcinoma. However, these cardiac glycosides did not affect normal human fibroblast cell multiplication, even at toxic doses.
Area of Science:
- Pharmacology
- Cell Biology
- Oncology
Background:
- Cardiac glycosides like strophanthin G and digoxin have potential therapeutic applications.
- Understanding their effects on different cell types is crucial for evaluating their safety and efficacy.
Purpose of the Study:
- To investigate the cytotoxic effects of strophanthin G and digoxin on various cancer cell lines.
- To compare the impact of these glycosides on tumor cells versus normal cells.
Main Methods:
- Experiments were conducted on lymphoid cells and carcinoma of cervix uteri cells.
- Three strains of cultured tumor cells were tested for growth inhibition.
- Normal human fibroblasts were exposed to highly toxic doses of the drugs.
Main Results:
- Both strophanthin G and digoxin demonstrated inhibitory effects on the growth of the tested tumor cell strains.
- No significant changes in cell multiplication were observed in normal human fibroblasts, even at high drug concentrations.
Conclusions:
- Strophanthin G and digoxin possess selective cytotoxicity, primarily affecting tumor cells.
- These findings suggest a potential therapeutic window for these glycosides in cancer treatment, with relative safety for normal cells.